Target (CBDY) EBITDA (2013 - 2026)
Target (CBDY) reported EBITDA of -$480825.0 for Q1 2026, down 333.19% year-over-year from $206196.8 in Q1 2025, and up 23.61% quarter-over-quarter from -$629409.0 in Q4 2025.
Target (CBDY) EBITDA (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of EBITDA data on file, last reported at -$480825.0 in Q1 2026.
- EBITDA for Q1 2026 came in at -$480825.0, down 333.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 524.03% YoY), and the FY2025 annual result was -$1.6 million, down 434.43% from the prior year.
- EBITDA rose to -$480825.0 in Q1 2026 per CBDY's latest filing, from -$629409.0 in the prior quarter.
- Over five years, EBITDA peaked at $740854.0 in Q2 2023 and troughed at -$747728.0 in Q1 2023.
- A 5-year average of -$141065.3 and a median of -$288901.0 in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2026: EBITDA jumped 516.72% in 2024, then slumped 333.19% in 2026.
- A 5-year view of EBITDA shows it stood at $217006.2 in 2022, then slumped by 154.08% to -$117354.0 in 2023, then jumped by 516.72% to $489032.0 in 2024, then slumped by 228.71% to -$629409.0 in 2025, then grew by 23.61% to -$480825.0 in 2026.
- Business Quant data shows CBDY's EBITDA at -$480825.0 in Q1 2026, -$629409.0 in Q4 2025, and -$403081.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -98.81 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Target | - | - | 191,787.00 | -480,825.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -480,825.00 |
| Dec 31, 2025 | -629,409.00 |
| Sep 30, 2025 | -403,081.00 |
| Jun 30, 2025 | -411,832.00 |
| Mar 31, 2025 | -110,997.00 |
| Dec 31, 2024 | 489,032.00 |
| Sep 30, 2024 | -600,110.00 |
| Jun 30, 2024 | 676,087.00 |
| Mar 31, 2024 | -99,941.00 |
| Dec 31, 2023 | -117,354.00 |
| Sep 30, 2023 | -288,901.00 |
| Jun 30, 2023 | 740,854.00 |
| Mar 31, 2023 | -747,728.00 |
| Dec 31, 2022 | 217,006.16 |
| Sep 30, 2022 | -301,468.00 |
| Jun 30, 2022 | 220,380.00 |
| Mar 31, 2022 | -549,824.00 |
| Dec 31, 2021 | -392,386.41 |
| Sep 30, 2021 | 2.13 Mn |
| Jun 30, 2021 | 906,695.00 |